With great enthusiasm Insights Success has selected some of the most prominent organizations around the globe in the issue of “The 10 Most Innovative Pharma and life sciences Solution Providers 2018,”
Helping Organizations Work Better and Faster with Data Science
1. January 2018January 2018
www.insightssuccess.comwww.insightssuccess.com The way of business solutionsThe way of business solutions
Adding Mobility to
Healthcare via EMR-EHR
Adding Mobility to
Healthcare via EMR-EHR
ExclusiveExclusive
Executive Talk
Top 5 Best Practices that Denes
a Successful Wellness Program
Top 5 Best Practices that Denes
a Successful Wellness Program
Executive Talk
LIFE
Most Innovative
Solution Providers 2018
SCIENCES
&PHARMA
10The
Trends To Be Followed
In Electronic Health Record System
Trends To Be Followed
In Electronic Health Record System
Tech-N-TrendsTech-N-Trends
Helping Organizations to Work Better and Faster
ORBYTEL GROUP:
Murt Abuwala
Founder
2.
3.
4. Pharma Industry
and IoHT
ith the invention of the IOT devices, nowadays every one of us are connected with each
Wother's all the time. The massive technological shift of this dimension is felt by every
division of the economy including healthcare. Internet of Healthy Things now bridges
interoperability hurdles to transform radically the way how healthcare is being delivered.
Wearable devices alongside home health monitoring systems are now more of a necessity rather than
life style devices. Whether data comes from electrocardiograms or temperature monitors, tracking
health information is always vital for all the patients. Thanks to the progress of science, now
wearable devices can facilitate real-time data reporting which include heart rate, sleep pattern, steps
taken, etc. Additionally, increased processing power of smart phones also has helped these devices to
be connected in a better way. The leaps and bounds that technological progress has taken in the last
few years showcases that whereas once you'd have to go to a medical practitioner to get more
information about.
Thanks to IoHT, it is slowly reducing the cost of healthcare delivery and helping the healthcare sector
to transform into a value-based system. According to various reports, with remote patient monitoring
for the heart, asthma, and diabetes patients around the globe will enable total saving of more than
$200bn yearly. The world is slowly adapting interconnected devices, and all these methods will
eventually help to build products that involve enough with patients to support them in crafting health
goals which are relevant to their life.
Editor’s Note
5. So with great enthusiasm Insights Success has selected some of the most prominent
organizations around the globe in the issue of “The 10 Most Innovative Pharma and life
sciences Solution Providers 2018,”. These organizations are transforming the life science and
pharmaceuticals industry with their revolutionary innovations and foremost initiatives that
mainly focus on the product acceleration and customer satisfaction.
The journey starts with Orbytel Group, a data science and decision system company that
exclusively serves the biopharmaceutical industry and driven the success with profound
solutions.
Then we have OSNEXUS Corporation, whose QuantaStor SDS is a software-defined storage
platform of the company that turns servers into multi-protocol (SAN/NAS/Object) scale-out
storage appliances and expertly improves the agility of associate organizations; Golden Helix,
Inc, which provides one of the best automation capabilities that are crucial in high-throughput
testing environments; Catalyst UX is also part of the list. It designs and builds User
Experiences (UX) for Medical, Pharmaceutical and Life Science Digital Solutions; then we have
Sciformix Corporation which is a leading scientific knowledge-based organization that
provides process, technology and consulting services to the life sciences industry; Ideagen Plc.
who provides quality, safety, audit, performance and risk management software and expertise
and has operations in the UK, the European Union, the United States, Middle East and Southeast
Asia.
Also, we have incorporated Exclusive- Adding Mobility to Healthcare via EMR-HER; Tech-
N-Trends- Trends to Be Followed in Electronic Health Record System; Care & Cure- The
Next Frontier of Innovation in the Pharmaceutical industry.
Lastly, don't forget to go through Executive Talk- Top 5 Best Practices that Defines a
Successful Wellness Program; Industry Insight- Contemporary Predictive Analytics in
Healthcare; Health POV- Hospital Logistics – Accelerating the Patient Flow in Danish
Hospitals.
Kaustav Roy
6. 08
CONTENTS
CoverStory
Orbytel Group:
Helping Organizations to Work Better and Faster
Trends To Be Followed In
Electronic Health Record
System
Tech-N-Trends
22
Adding Mobility to
Healthcare Via EMR EHR
Exclusive
34
The Next Frontier of
Innovation in the
pharmaceutical industry
Care & Cure
40
Articles
Top 5 Best Practices that
Denes a Successful
Wellness Program
26
Hospital Logistics –
Accelerating the Patient
Flow in Danish Hospitals
32
Executive Talk Health POV
7. Golden Helix:
18
Helping Researchers and Clinicians
Understand the Role of CNVs in
Human Health and Disease
Catalyst UX:
16
Driven by Software, Empowered
with Experience
Ideagen:
24
The Undisputed Leader in the
Governance, Risk and Compliance
(GRC) Marketplace
OSNEXUS:
30
A Leading Hyper-Scale Software
Dened Storage Provider for Life
Sciences
Sciformix:
42
Bridging the Gap in Life Science
Service Delivery with Deep Scientic
Knowledge, Providing Quantitative
and Qualitative Value
Contemporary
Predictive Analytics in
Healthcare
38
Industry Insight
11. ORBYTEL
GROUP:
ORBYTEL
GROUP:
Helping Organizations
to Work Better and Faster
At the heart of our solutions is Harmony,
our custom-built, patent-pending,
cloud-based platform designed from
the ground up to meet the unique needs
of the biopharma industry.
“
“
Cover Story
12. Cover Story
vercoming the differences in culture and
Ocommunication between commercial and research
organizations is a challenge especially when it
comes to biopharmaceutical R&D productivity. In order to
remove these barriers, Orbytel Group, a data science and
decision system company, builds solutions that help teams
structure, manage, and act on complex data.
The vision of Orbytel Group is to empower scientists,
physicians, business professionals, and patients to radically
improve therapeutic development and delivery.
A Veteran Leader
With more than twenty years of experience in the
pharmaceutical industry, Murt Abuwala founded Orbytel
Group in 2009. When he invented a mathematical and
experimental approach to identify potential medicines for
neurodegenerative diseases, such as Alzheimer’s Disease,
he was thrust into the commercial side of the industry. After
working in sales, marketing, analytics, IT, managed care,
and corporate finance he became a consultant to the
industry.
When asked about this future plans, he stated “We want to
make science easier for business people and business easier
for scientists. This divide is at the root of the R&D
productivity problem facing large companies and our
aspiration is build tools that help bridge the gaps between
these two very different and important groups.”
After leading two successful consulting teams at major
firms, Murt started Orbytel Group in order to focus on how
organizations can improve decision making. He has worked
with more than thirty publicly-traded global
biopharmaceutical companies, including 7 of the top 10 in
M&A, portfolio analytics, commercial strategy, R&D
strategy, sales strategy, and medical strategy.
Murt is a Phi Beta Kappa, magna cum laude, and honors
graduate of Oberlin College with a degree in biochemistry.
He was part of the student government, played varsity
tennis, and received awards and grants from the National
Science Foundation (NSF), Howards Hughes Medical
Institute (HHMI), and the American Chemical Society
(ACS) for his research.
A Unique Organization Taking On the Challenges of the
Industry
According to Orbytel Group one of the most significant
challenges facing the industry is the ever-increasing cost of
bringing an asset to market. This challenge is magnified by
the increasing pricing pressure biopharma companies are
facing. Consequently, companies are seeking ways to
reduce costs and find efficiencies. Orbytel Group believes
that the core of this challenge is pipeline asset assumption
management. Assumptions about clinical differentiation, net
pricing, reimbursement, product uptake, and promotional
response need to be vigorously reviewed, debated, and
carefully managed to ensure R&D investments that are
generally made over 10 years and are in the hundreds of
millions dollars reflect future market realities.
To address this large complex challenge, companies have to
organize large volumes of data across many disciplines,
develop analytic standards, and standardize decision
making processes across thousands of individuals. It is a
large high-risk cross-functional initiative that most
companies are reluctant to undertake. Through its extensive
and unique experiences with most of big-pharma for many
years, Orbytel Group had a unique perspective. It took the
best practices from many companies and created data
standards and a common data structure. Following that,
Orbytel created a custom technology platform designed for
business planning and competitive intelligence. It allows
end-users to interact, visualize, and act upon data
consistently towards a common goal regardless of their
department or discipline.
Helping Organizations to Make Better Decisions
Orbytel Group helps companies to manage, organize, and
act on data so they can make better decisions. The
organization mainly works in three areas - R&D/Medical
Affairs, Finance, and Sales.
Within R&D/Medical Affairs, Orbytel offers two solutions:
Meeting Assistant and Trials. These modules are focused on
structuring complex clinical and scientific data in a way that
is easier to understand, analyze, summarize, and
communicate. They enable companies to track and manage
much larger volumes of data which in turn improves their
understanding of data generation opportunities and risks.
For Finance, Orbytel offers a Forecasts module to help
teams create, manage, and communicate long-term product
valuations. It replaces MS Excel, standardizes forecasts
across assets, countries and teams, and enables teams to
understand the long-term financial implications of various
clinical data scenarios. In short, it helps determine how to
best direct R&D dollars.
Orbytel Group also helps companies run their sales forces
more profitably. The solution provided by Orbytel
simplifies sales operations & analytics, optimizes sales
13. strategy on financial goals, and reduces dependency on
multiple third-party systems and vendors. Through
sophisticated analytics and reporting, data is presented in a
way that helps individuals make better decisions. For a
sales force of fewer than 100 individuals, a VP of Sales is
able to run the entire system and process with no need for
dedicated sales operations or analytics staff. This unified,
highly-streamlined application assists enterprises in dealing
with an increasingly difficult selling environment by
lowering operational complexities and expenses.
Thanks to the innovative solutions provided by Orbytel
Group, clients are now able to reduce costs and increase
efficiency. They believe that by being able to make better
decisions more consistently, its clients also gain broader
strategic and competitive advantages.
Entering the Vertical
Murt started his career in pharma R&D as a chemist nearly
twenty years ago and has always worked in the
pharmaceutical industry. Orbytel Group will continue to
focus on this industry. Murt believes the biopharma
industry is currently under pressure but that it will come out
stronger than ever and will have a profound impact on
health in the next 30 years.
“The biopharma industry is at the cusp of an amazing
intersection of genetic understanding, biological
manufacturing capacity, and portable computing power.
Truly amazing things are happening, and Orbytel Group is
excited to be a part of the growth and optimistic that it will
“
“
Orbytel creates
and implements
data structures
and processes
that improve the
way in which
scientific, clinical
and financial data
is visualized,
managed, and
communicated.
14. Cover Story
have a role, however small, in positively impacting patient
health outcomes.”
Tackling Initial Rough Days and Future Plans
Orbytel Group started working on their technology in 2014,
but did things backwards
from the “norm”. Rather than
starting with the UX/UI,
Orbytel focused on the data
model. They approached it as
an exploration of whether it
could create a unified data
model for the biopharma
industry that could structure
data in a meaningful way for
R&D, finance, and
commercial simultaneously.
Additionally, Orbytel Group
worked on a data security
model to easily handle the
unique firewalls in the
biopharma industry while
also permitting the secure
flow of data between
departments compliantly. This
created a low-level blueprint
for the data structure it
wanted to ultimately achieve.
When Orbytel was happy
with its design, it looked for
an application development
platform to start building
applications in which data
flowed seamlessly and
could easily automate
workflows. Nothing
readily available
worked, and they made
the tough - and
expensive - decision to
build their own
platform called
Harmony.
It took about a year to
create the core platform
and another year to
work out the kinks,
polish its features, and
improve the UI. Their next big challenge was customer
acquisition.
Finding individuals who were willing to listen and lead
change via a new and potentially disruptive technology was
difficult. Orbytel ended up
coupling its new software
products to its established
services at strategic accounts.
This helped to establish a
track record and gradually
increase their user base.
According to Orbytel Group,
starting with the data-model
and building a platform from
scratch was risky but
everything fell into place
eventually. Once people
experienced the product’s
benefits and the company’s
service, they grew open to the
changes and many provided
referrals. In fact, in 2017
alone, their user base grew by
over 300-fold and is still
growing each month.
Orbytel’s software is coupled
with data and analytical
services, training, and
professional services - a
unique full-service offering
that its top-tier clients
demand. Orbytel is very
proud to have a 100
percent customer
retention rate for the
past 7 years. They plan
on growing their user
base with their existing
products and expanding
their product offerings
to additional areas of
R&D.
“
“
We provide
Software-as-a-
Service (SaaS) to
help our clients
accelerate
therapeutic
development and
optimize
commercial
success.
15.
16. Address :
Country :City : State : Zip :
Global Subscription
Date :
Check should be drawn in favour of : INSIGHTS SUCCESS MEDIA TECH LLC
Never Miss an Issue
Yes, I would like to subscribe to Insights Success Magazine.
Name :
1 Year.......... $250.00(12 Issues) .... 6 Months ..... (06 Issues) ..... $130.00
3 Months ... (03 Issues) .... $70.00 1 Month ...... (01 Issue) ..... $25.00
Telephone :
Email :
Insights Success Media Tech LLC
555 Metro Place North, Suite 100,
Dublin, OH 43017, United States
Phone - (614)-602-1754,(302)-319-9947
Email: info@insightssuccess.com
For Subscription : Visit www.insightssuccess.com
SUBSCRIBE
TODAY
CORPORATE OFFICE
17. ManagementCompany Name
Catalyst UX
catalystux.com
Paul Giurata
CEO
Catalyst UX designs and builds User Experiences (UX) for
Medical, Pharmaceutical and Life Science Digital Solutions.
Golden Helix, Inc
goldenhelix.com
Andreas Scherer
President & CEO
Golden Helix provides automation capabilities that are crucial
in high-throughput testing environments.
Ideagen Plc
ideagen.com
David Hornsby
CEO
MethodSense
methodsense.com
MethodSense guides medical device, biotech and
pharmaceutical companies with quality, regulatory and
technology solutions. Our regulatory compliance consulting
enables clients to operate more effectively during the
commercialization process and beyond.
Murt Abuwala
CEO
Orbytel Group, a data science and decision system company
that exclusively serves the biopharmaceutical industry.
OSNEXUS Corporation
osnexus.com
Steven Umbehocker
Founder & CEO
OSNEXUS’ QuantaStor SDS is a software-defined storage
platform that turns servers into multi-protocol
(SAN/NAS/Object) scale-out storage appliances.
PENDOPHARM
pendopharm.com
Dr. David Goodman
CEO
From allergy to gastroenterology to specialty prescription
products, PENDOPHARM specialises in several different
therapeutic classes.
Sciformix
sciformix.com
Manish Vinayak Soman
President & CEO
Simpson Healthcare
simpsonhealthcare.com
Kelly Simpson
CEO
Simpson Healthcares’ purpose is to support its clients to share
the scientific story of the diseases they touch and the therapies
they discover all in need.
Ideagen provides quality, safety, audit, performance and risk
management software and expertise and has operations in the
UK, the European Union, the United States, Middle East and
Southeast Asia.
Sciformix Corporation is a leading scientific knowledge-based
organization that provides process, technology and consulting
services to the life sciences industry.
Ocean Data Systems
dreamreport.net
Rick Pierro
President
Dream Report™ is taming that ocean of data! It’s the first
programming free, user-friendly, automated reporting and data
analysis software designed specifically for industrial automation
applications.
Brief
Russ King
President
Orbytel Group
orbytelgroup.com
1
M O S T I N N O V A T I V E
SOLUTION PROVIDERS 2018
H RM
L FE SC ENCES
&The
18. Famed Canadian physician William Osler once
said, “Medicine is a science of uncertainty, and an
art of probability.” Since Osler’s time, the
medical and pharmaceutical industries have changed
dramatically—but that unpredictability remains. And
while many medical and pharmaceutical companies have
come and gone—others have managed to make a mark in
the long run with a sustainable forward-thinking
approach focused on understanding the evolving needs
of providers, patients, employees and customers.
Enter Catalyst UX—a full service user
experience (UX) firm that helps the
medical, life sciences, and
pharmaceutical industries cater to
these shifting demands with
adaptive, responsive
application and software
design that makes life easier
and more productive for
these users. Backed by more
than 25 years of experience
spanning 500+ projects, the
company blends human
behavior research and
testing, digital strategy, UX
design, and UI development to
help its clients deliver
thoughtful, consistent experiences
across platforms and devices.
Impeccable End-to-End
UX Design and UI
Development
Catalyst UX takes a
comprehensive approach to UX design—providing each
of its clients with a two- to six-person team of UX
architects, UX designers, UI developers and social
scientists. Those teams are singularly committed to
creating elegant and simple software designs that help
employees, providers and patients access data and
services, ensure the proper use of medical instruments
and seamlessly extend their user experience to almost
any mobile device. This proven approach means the
team can offer unrivaled speed to market—delivering
complete design and coded UI in less than 100 days.
The Internet of Things (IoT) and other emerging
technologies have brought rapid change to the world of
medical devices. To that end, Catalyst UX has put a
strong focus on developing software that incorporates
and connects with a broad array of hardware and
instruments. Cloud technologies have also
opened a world of new opportunities in
the medical industry. The company
combines big data analytics,
privacy-by-design practices,
collaboration and a strong
knowledge of regulatory
requirements to help any
organization with this
transition.
Astuteness of CEO, Aiding
to Thrive
The visionary behind
Catalyst UX and its
sustainable developments is
CEO Paul Giurata. The
Colorado native earned a BA in
Electrical Engineering from the
University of Colorado, Boulder, before
going on to complete an
MBA at Santa Clara
University. Before founding
Catalyst UX, he made his
name at Apple, where he transformed numerous
education-focused research projects into commercial
solutions. Later, he moved on to Hewlett Packard
Medical Products (Agilent), where he played a key role
in the sale and installation of patient monitoring,
cardiology, neonatal and diagnostic imaging products in
Catalyst UX:
Driven by Software, Empowered with Experience
16
Catalyst has deep experience with complex solutions across
the medical, pmarmaceutical and Life Science fields
January 2018
19. Latin America, Africa, the Middle East, China, and
Australia.
Mr. Giurata is one of the world’s most experienced
solution architects and has led the company with his
proven knack for defining successful products and
delivering simple but elegantly designed solutions.
Delivering Consistency in an Unpredictable World
Paul asserts, “We guide our efforts with meaningful
Paul Giurata
CEO
We are a team
of passionate UX Designers,
UI Developers and Social Scientists
committed to creating innovative
user experiences that grow
companies, create new markets
and improve lives.
‘‘
‘‘
observation of users, patients, scientists and caregivers
to inspire solutions” The company has faced its share of
challenges over the years, but by using proven
methodologies, committing to collaboration and building
teams that are truly passionate about the work they are
doing, he’s turned these setbacks into opportunities.
Today, the company delivers the latest technologies and
optimized user experiences to promising industry up-
and-comers, and further aims to build on such
collaborations. Catalyst UX helps pharmaceutical and
medical companies
improve patient
outcomes,
accelerate
discoveries and
make a meaningful
impact on mankind.
Going forward,
Giurata’s goal is to
collaborate with
global leaders—as
well as emerging
innovators—to
deliver empowering
medical, life science
pharmaceutical
solutions.
17
1
M O S T I N N O V A T I V E
SOLUTION PROVIDERS 2018
H RM
L FE SC ENCES
&The
Paul Giurata working with his Team
January 2018
20. Founded in 1998, Golden Helixis a global
bioinformatics firm. Since foundation, the
organization has accumulated a significant customer
base and is currently working with more than 350
organizations—with thousands of users leveraging the
organizations’ various analytics products. From its early
days till the present-day, GlaxoSmithKline has been the
largest outside investor of Golden Helix. Till date the
organizations’ software has been referenced in more than
1000 publications. The customers of Golden Helixfall into
five primary categories: testing labs, hospitals,
pharmaceutical companies, major research organizations
and government organizations.
A Well-known Leader
Back in 2013 with the objective of leading the business into
genetic testing market, Andreas Scherer joined Golden
Helixas the President and CEO. While working for
organizations like Netscape and AOL as a Global Vice
President, Andreas gained much needed valuable insights in
running world-wide businesses which require functional
know-how in sales, marketing, product development,
services and operations.
His educational background is centered around Computer
Science in which he holds a PhD from the University of
Hagen, Germany. Andreas has so far published more than
twenty peer reviewed articles, authored books on Neural
Networks, Intranets and Project Management. His latest
book, “Be Fast Or Be Gone” was a prizewinner in 2012
Eric Hoffer Awards competition.
In his private time, Andreas enjoys weightlifting throughout
the year. In the winters, he likes to spend time skiing the
mountains of Montana and in the summer, you can find him
on the golf course.
Empowering End Users to Perform High-End Analytics
Work
Golden Helix’s main goal is to empower their end users to
perform high end analytics work. This is achieved by
producing software which gives the power of analysis to
researchers, supporting them through their analysis, and by
providing them with genomic services when the need
arises.
Golden Helix takes pride in itself for creating software tools
that are integrated and robust, but more importantly user-
friendly and intuitive. The tools are specifically created in
order to empower biologists, clinicians and other
researchers to easily perform complex analyses and
visualizations, eliminating the need to rely exclusively on
bioinformatic experts or cobble together difficult to use,
incompatible freeware. This way researchers can
completely focus on their research instead of learning to be
a programmer or waiting in line for bioinformaticians.
The organizations’ support team is motivated by one
mission—to make sure that the customers have a great
experience with their software tools. From helping to
import data, bug detection, and finding technical resources,
Golden Helixis fully committed to providing its customers
with the resources they need in order to complete their
analysis in a world-class manner at a lightning fast pace.
The organization doesn’t just stop at support, it also offers
comprehensive and personalized training sessions to help
researchers jumpstart their research. Golden Helix’sField
Application Scientists and Engineers help researchers by
taking them through workflows that are relevant to their
specific research.
Ground Breaking Products
Golden Helix has developed a powerful technology stack
that supports a number of products in the genomics space,
including the following:
Ÿ VarSeq: VarSeq is an intuitive, integrated software
solution for tertiary analysis. With VarSeq you can
automate your workflows and analyze variants for gene
panels, exomes and whole genomes.
Ÿ VS-CNV: Directly calls CNVs in target regions and
Golden Helix:Helping Researchers and Clinicians Understand
the Role of CNVs in Human Health and Disease
18 January 2018
21. Ÿ avoids the cost and turn-around time of additional CMA
or MLPA testing.
Ÿ VSPipeline: Repeatable clinical workflows essential for
CLIA and CAP certified analysis, creation of high
throughput pipelines and access to curated annotation
sources that are updated regularly.
Ÿ VSReports: With VSReports, you can easily convert the
output of your tertiary analysis into a customized
clinical report. After you’ve filtered down your imported
variants, simply select variants to include in the report.
Ÿ VSWarehouse: A scalable, multi-project warehouse for
NGS variant call sets, clinical reports and catalogs of
variant assessments.
Ÿ SNP & Variation Suite (SVS): SNP & Variation Suite is
a powerful analytic tool created specifically to empower
biologists and other researchers to easily perform
complex analyses and visualizations on genomic and
phenotypic data.
Ÿ GenomeBrowse: A powerful tool that delivers stunning
visualizations of your genomic data that gives you the
power to see what is occurring at each base pair in your
samples.
A Different Organization
When it comes to client handling and providing support,
Golden Helixis a completely different organization from its
competitors mainly due to:
Ÿ Pervasiveness: The company has a strong competence
building on-premises solutions for the life science space.
To date, many labs, hospitals and government
organizations prefer to control the IT environment over
cloud solutions. However, as the clinical testing space
goes mainstream, cloud deployment models are
Andreas Scherer
President & CEO
We provide a complete
end-to-end solution for
clinical labs and hospitals to
analyze Next-Generation
Sequencing data
‘‘
‘‘
attractive for certain market segments. Golden Helix’s
future development plans include a strategy to deploy
the Golden Helix stack in a way that customers can pick
and choose their preferred deployment model:
Ÿ On Premises: Currently, the main deployment mode for
Golden Helix. This continues to be a highly desirable
approach as hospitals and testing labs are concerned
about hosting patient data outside their premises.
Ÿ Cloud: Certain segments of the market have accepted
cloud solutions as viable. The company is extending out
technology stack in this direction.
Ÿ Mix Deployment: For certain deployment scenarios, a
mixed approach is preferable. For example, in certain
scenarios it could make sense to run the analysis and
clinical reports pipeline on premises and store all the
resulting data in a cloud hosted data warehouse.
Ÿ Internationalization: The US has been a strong market
for clinical testing and research analytics products and
services. However, selected markets in Europe, Asia and
Latin America, as well as Australia and the Middle East
are increasingly important. Golden Helix’s mid-term
strategy is to increase its local presence in these markets
either through partners or directly.
Ÿ Preservation: Golden Helix has a strong customer base
with a high renewal rate. Its high rate of customer
satisfaction and the stickiness of its solution is one of
the reasons why Golden Helix has been highly capital
efficient. The organization continues to focus on a high-
quality customer experience to encourage future
renewals.
19
1
M O S T I N N O V A T I V E
SOLUTION PROVIDERS 2018
H RM
L FE SC ENCES
&The
January 2018
22.
23.
24. Medical Science is something which is growing at
a very fast pace. For noting down the diagnosis,
the doctor no more requires a pen and paper.
Even the words “Electronic Health Records” are not new to
the today’s world, but the upcoming trends of Electronic
Health Records (EHR) or Electronic Medical Records
(EMR) are interesting.
Even the medical trends like gamification, wearable,
telemedicine, mobile medicine and 3D printing are now old
concepts, but their modifications are some of the amazing
thing to witness. Science will never reach its peak as the
sky's the limit and nothing can stop it. 3D printing has
changed the medical technology to an extreme level by
creating custom prosthetic, surgical implants and bio-
printed tissue. Experts say that the world is soon going to
see 3D printed drugs too.
While one discusses about the most emerging trends in
EMR-EHR, the person cannot miss talking about the
following:
Everything is in the cloud
With the cloud technology, keeping medical records are
much cheaper and easier to access. As per technologists,
nothing is more portable than cloud as it only requires a
computer or a smartphone with internet connection in it.
Research has informed that the on-premise EHR can cost
about $40,000 to set up, but the cloud-based EHR
infrastructure and maintenance costs include its monthly
charges just missing the high startup costs, are still lesser
than the in-house EHR.
The common benefits of cloud-based EHR include the
security factors, privacy, cost effectiveness, accessibility,
Trends To Be Followed
In
Electronic Health
Record Systemreduced It requirements, better continuity of care, easier
updates and improvements to software and the most
amazing plus point is that it is customizable according to
choices.
Providing patient portals
Another most growing trend is the patient portals. It is
something which helps the medical practitioners in
increasing the quality of the patient care and in reducing
medical errors. While a group of people was educating the
patients about the procedure of using the portal, they
informed that the people are interested in using a medical
portal to engage themselves directly to the physicians. This
helps them to track their medical history, receive education
materials, medical advices and patient support.
The portals provide some interesting features such as
prayers for patients, direct access to their medical records,
personalized health reminders and total health programs
such as personalized diet charts, exercise lists, and
medicinal guidance.
Telemedicine is the new medical tool
The dictionary defines telemedicine as the remote diagnosis
and treatment of patients by using telecommunications
technology. Experts clearly mentioned the benefits of this
new medical tool like that with this the medical
practitioners can easily give care to remote and homebound
patients in a much-reduced cost of care while eliminating
the risk factors of picking up new illnesses in a clinical care
setting and providing more flexibility to providers.
Reports suggested that the newly medicinal tool is currently
helping recovering stroke patients in many rural areas of the
United States of America. The adoption of wearable is
Tech-N-Trends
January 201822
25. helping doctors to provide better patients care through
telemedicine. And Transparency Market Research has
estimated that the valuation of global video telemedicine
market would rise to $1,624.4 million by the end of 2020.
Building trust on the influx of data is the most
important factor
There is nothing more important in optimizing in operation
through EHR than building the trust on the data that is
being captured as there is always a major connection
between trust, data, and value-based healthcare. Experts
suggest that nothing can be an ideal opportunity than
building a bridge between the healthcare providers and
technology companies. The most important part is filling
the gap with trust between the insurance partners as without
that the stakeholders would not be willing to make data
accessible for one's practice that will ultimately lead to
various issues.
Security remains the main concern
The world is developing at a rapid speed, and so is the
medical technology. With technological advancements,
EHR is improving itself, but the security concerns are
increasing too. As per some old reports, a data breach costs
an organization of an average total of $3.8 billion. It was
reported that the 49 percent breaches in the U.S are the
result of criminal attack rather than human error or a system
glitch. Experts commented that cyber-attacks might come
from outside an organization, but the executives of the
hospital itself are concerned about the security
vulnerabilities created by the employees. As reported by
Fierce Healthcare, “Nearly 60 percent of breaches in the
month of February were the result of insider threats.
According to the most recent Protenus Breach Barometer
Report, 44 percent of incidents in March were triggered by
insiders.”
EHR is no more unknown to the people, but the
modifications within that are. It’s improving living
conditions and better healthcare facilities. Investors might
find it interesting that this sector is a growing sector and
new changes are always accepted. By the same time, it is
also important to note that though all these trends are
growing, it still requires too much attention and massive
developmental investments.
January 2018 23
26. Launched in 1993, Ideagen is a UK based public
company that provides quality, safety, audit,
performance and risk management software and
expertise. Having operations in the UK, the European
Union, the United States, Middle East and Southeast Asia,
the company also boasts a global network of partners
servicing Asia Pacific, Europe and South America.
Ideagen has a customer base of more than 3,000
organizations using its suite of products, including many
blue-chip names such as BAE Systems, Ryanair, Heineken
and the European Central Bank. Ideagen also counts over
150 hospitals in the UK, US and beyond as part of its client
base. Ideagen has grown both organically and through a
number of strategic acquisitions, and this year recorded its
th
8 consecutive year of growth in revenue, adjusted
EBITDA and adjusted earnings per share.
A Dedicated and Ambitious Leader
Ideagen CEO, David Hornsby, is a Scottish-born,
Yorkshire-raised businessman. He attended Leeds
Grammar School and then Sedbergh Boarding School in
Cumbria before attending university. He started his
professional career as a Salesman, before forging a path
through the sales ranks of several computer software
companies. In 2009 he was introduced by his broker,
FinnCap, to software firm Datum International, a precursor
of the current Ideagen. Having invested £250,000 into
Datum, there followed several acquisitions and the
modern-day Ideagen was born.
The Undisputed Leader of the Industry
Ideagen’s software, particularly its cloud based product
Coruson, is leading the industry in terms of modern GRC
systems. It is an enterprise cloud software that provides
complete control, visibility, and real-time reporting of
every detail and aspect of safety and operational risk in an
organization. The product is a favorite amongst clients as it
is scalable, extremely user-friendly and functionally rich.
Indeed, it was Coruson’s user friendliness that was a major
factor in the product being chosen by the International
Airlines Group (IAG) – owners of British Airways, Iberia,
Vueling and Aer Lingus – Ryanair and Jaguar Land Rover
to name a few. The product also received the GRC 20/20’s
Environmental Health & Safety Technical Innovation
award for its user experience, analytics and mobile
capability.
Another unique area of Ideagen is the level of expertise
within the firm’s 400-strong workforce. This is a huge
selling point for organizations looking to do business with
Ideagen. Looking at quality, safety, audit and risk
management, Ideagen has industry experts with decades of
experience in each of these areas. Indeed, some of
Ideagen’s staff involved in the internal, operational and
financial audit areas have been praised by clients during the
procurement stage as being some of the most
knowledgeable experts they have worked with.
Equipping Clients with World Class Tools, Services,
and Expertise
Highly regulated organizations require the tools, services,
and expertise that Ideagen provides to help them identify,
assess and manage corporate risk while complying with
international industry standards. Many of these
organizations are only in the early stages of adopting an
enterprise-wide approach. Ideagen’s software tools enable
organizations to identify, assess and prioritize risk and
manage information in line with rigorous regulations. In
each of the chosen verticals, Ideagen’s customers are
increasingly required to take a holistic view of risk
management, internal audit and compliance, with many
organizations at the beginning of the adoption phase of
high value enterprise-wide solutions. In short, its software
Ideagen:
The Undisputed Leader in the Governance,
Risk and Compliance (GRC) Marketplace
24 January 2018
27. solutions enable them to comply with regulations that
allow them to operate.
Ideagen sees its cloud solutions as a particular area of
growth which will increase the percentage of total revenues
derived from recurring contracts.
Why the Pharma and Life Science Vertical was a
Natural Move
Alignment with highly regulated vertical industries was a
natural move for Ideagen. The pharma and life science
vertical is still a highly regulated one, and the software,
services, and expertise of Ideagen is a natural fit for
organizations that operate there. It is a volatile and ever
changing regulatory environment, but Ideagen’s products
help these organizations demonstrate high levels of quality
and compliance with a number of international standards
and regulations such as ISO, the FDA (including 21 CFR
Part 11), US Department of Agriculture (USDA) and
MHRA.
More than 200 Life Science organizations worldwide
including Reckitt Benckiser, Reading Scientific Services
(RSSL) and Roslin Cells, rely on Ideagen to help them
improve the management of their compliance processes
and information, increase overall business efficiency and
maintain data integrity to transform the management of
compliance activities from a costly overhead into a
business benefit.
Future RoadMap
In order to drive growth, Ideagen has successfully added
new customers to the Group across all of its key GRC
verticals, with aviation, life sciences and financial services
providing particular notable success in the year. The
organization will also continue to maintain a focus on
product enhancement and innovation, which has seen
acceptance across the user base, resulting in significant
revenues from strong retention of recurring contracts and
new projects from its extensive customer base.
Furthermore, Ideagen remains committed to its ongoing
buy and build strategy and would expect to complete
further acquisitions in the future assuming targets meet its
criteria and represent value for shareholders.
To facilitate the growth of recent years, Ideagen will
continue to invest in its employees, products and
infrastructure. Significant resources will also be invested in
benchmarking processes and systems to ensure best
practice is standard and that Ideagen remains fit for growth.
Ideagen remains committed to the relevant accreditations,
and currently holds Microsoft Gold Partner status, ISO
9001, ISO 27001, and ISO 14001.
David Hornsby
CEO
With an excellent portfolio of
software products, Ideagen helps
the world's leading brands to
improve operational efficiency,
strengthen compliance and
oversight and anticipate and
manage every detail of risk. This
enables organizations to reduce
costs and improve efficiency
‘‘
‘‘
25
1
M O S T I N N O V A T I V E
SOLUTION PROVIDERS 2018
H RM
L FE SC ENCES
&The
January 2018
28. Over recent years, more companies
are incorporating wellness
initiatives into their office
environment. It’s mission critical in todays
competitive markets, to attracting and retain
the best talents. One crucial measurement is
the engagement levels of everyone in the
entire organisation. Presenteeism is at an all
time high. People are not motivated by
money alone, and wellness programs are part
of the strategy to improve job satisfaction
and productivity. However, only a few
companies actually have comprehensive
programs that produce better health
outcomes among employees. As a result,
improved engagement and performance at
work, naturally follows since employees are
healthier and happier.
Unfortunately not all health and wellness
programs are successful. The first one or two
initiatives may gain traction, but two years
on, and the participation rates decline. One
main problem is that the participants
themselves aren’t part of the creation. Their
needs and concerns aren’t addressed so
there’s less motivation for them to commit.
So what do employees want? Here are 5 best
practices that help create successful
corporate wellbeing programs that gain true
engagement.
1. Programs Are Doable, Accessible and
Sustainable
Imagine a wellness talk or fitness class is
About the Author
Dr. Gary Tho is the owner of Chiropractic Works, a Family Sports and Wellness clinic in
Orchard Road, Singapore. He specialises in pain relief and preventative care and believes
quality life is essential for happiness, success and peak performance. Dr Gary is also the
author of The Pain-Free Desk Warrior, Free yourself from aches and pains which is the
definitive guide for those stuck at their desk for more than 2 hours a day.
Top 5Best Practices that De nes
a Successful Wellness Program
Executive Talk
January 201826
29. starting in 15 minutes. Many
employees easily dismiss it and think
“I’d love to go, but I really need to get
this work done.” Do programs run
when employees are most busy? Are
run after office hours? And if so, will
people stay back for it? Is the wellness
program a broad-based and holistic
approach? Or is it just yoga classes,
cooking demonstrations and nothing
else?
Is it easy for participants to learn?
What looks easy when a trained chef
prepares a healthy dinner in 20 minutes
could take the average person a lot
more time, energy and stress. Are steps
provided for one to implement the new
habit, accomplish their goal and sustain
the success?
A comprehensive wellness initiative
needs to offer a variety of scheduled
programs that are broken down into
achievable, sustainable habits that
create a valuable outcome. Equally
important is that employees can choose
what they are interested in, and easily
fit into their schedule.
2. The Work Environment Is Health-
Conscious
It’s no use having health and wellness
programs if the physical and
psychosocial environment within the
office does’t support to healthy habits.
Great office design that support
wellbeing has been the trend, since
Facebook and Google showed us how
to do it.
Creating creative spaces for smaller
pod meetings, having standing desks
and ensuring the cafeteria and vending
machines around the office offer
healthier food choices that can be
easily seen are some of the simple
ways to encourage good health.
Ensuring regulated noise, inspiring
music, good air quality and
temperature and adequate lighting are
also simple yet impactful features of a
great office space.
Allowing ‘down’ times, and work
breaks that are encouraged, is essential.
Most people don’t take breaks or chit-
chat because of its negative perception.
However this is absolutely necessary
as it create real interaction and real
friendships between co-workers that
satisfy the basic human need for social
connections. People need other people
to love, trust and support them, in both
business tasks as well as at a personal
level.
3. Wellness Is Integrated Into The
Company’s Structure
Further to point 2 above, choosing a
healthier lifestyle and doing well at
work shouldn’t feel like a tug-of-war.
I’ve heard of companies who pay for
gym memberships for their staff, which
is great. However, when an employee
is working out in the gym, they get a
phone call saying they need to get back
in the office because of … (some
reason). Therefore it’s important that a
company establishes wellness
programs that are valued and honored
in every aspect of the organization.
Otherwise, what’s the point? Another
example includes the holy grail of
“work-life balance”. If your company
wants employees to be healthy and
have better work-life integration, yet at
the same time silently imposes that
people must continue working beyond
standard office hours, it really does not
make any sense. One (partial) solution
to this is introducing flexi-hours as
well as remote working to allow people
to get errands and family engagements
done, as well as work from home, or a
cafe instead of being physically in the
office. It’s a partial solution because
giving someone the ability to run
errands and come to work later than
usual is great, though it does not
necessarily promote health, happiness
or wellbeing.
4. Wellness Is Linked To Continued
Support Programs
When a company is genuinely
concerned about their employees’
wellbeing, they will naturally ensure
that any wellness initiative, game or
workshop has some form of
continuation. Employee assistance
programs (EAP) are common for
mental health concerns, however there
needs to be other support systems in
place for other health concerns. In
2014, Apple’s Cupertino, Calif.-based
headquarters boasted a medical one-
stop-shop “wellness center” offering
in-house chiropractic care, dieticians
and more. Collective Works,
Singapore, the largest premium co-
working space in Asia, now also
houses an in-house chiropractor,
specializing in pain relief, peak
performance for both individual and
corporate health.
Gamification of corporate health
programs usually run for a certain
period of time. Workshops and classes
may run for 8 weeks or throughout the
entire year. Although participation
rates are high initially, continued
support programs are what sustains
engagement, and creates the change
both individuals and the CEO’s want to
see. Engagement is what creates long
term sustainable results.
5. Broad-based Approach
Wellness Programs aren’t all about
offering free gym membership or just
having smoking cessation programs.
Health is health - a complete state of
physical, mental, and social well-
being. Fitness is “the ability to perform
work (sports, occupations and daily
activities) satisfactorily”. Pilates is a
great way to exercise and strengthen
the core muscles, however it is not
equivalent to health.
A lot of people know they should quit
smoking but doesn’t because they
don’t realize how much damage it can
do to their body. They may not have a
strategy, nor enough motivation to
make those changes. One method of
offering voluntary health screenings
while giving sound education and
simple tasks from a variety of
professionals is the key. Helping
people realise that the company does
care, that their colleagues do care, that
they too should care about their own
health is of the greatest importance.
Digging deep, and creating a safe place
to improve their lifestyle choices on
multiple levels should be the basis of
every corporate wellbeing initiative.
January 2018 27
30.
31.
32. The internet has become a massive repository of
information, an important advertising medium, and
the ideal cloud storage management service for
almost every industry. From small startups to multinational
companies, organizations are storing massive amounts of
enterprise data and information relevant to their operations
on websites. They all require an efficient and scalable
storage platform to maintain and organize this information.
Life Sciences organizations today are struggling to keep up
with massive data growth due to advancing technologies,
and sectors like Genomics are producing up to 40 exabytes
of data per year.
The current market is crowded with storage providers, most
of which offer a traditional model known as the ’multitude
of silos’ construction. However, organizations find it
difficult to organize their data using that traditional model; a
unique and adaptable solution is becoming increasingly
essential.
A new data storage model called Software Defined Storage
came into play to solve some of the problems associated
with legacy storage systems such as high prices for
software and hardware combinations and vendor lock-ins.
With Software Defined Storage, companies can buy
commodity hardware and install separate software to
manage their data; a more economical approach than
traditional storage systems.
OSNEXUS Corporation (OSNEXUS) stands out as a
Software Defined Storage company with its storage grid
technology that is built into its QuantaStor SDS platform,
which simplifies storage management by allowing all data
to be managed from a ’single-pane-of-glass’ web interface
which requires no additional software to install; a leap in
progress for open storage platforms.
QuantaStor SDS enables organizations to use standard
server hardware as their storage appliances but OSNEXUS
has gone further to provide reference configurations and
certifications with every major server manufacturer on the
market which provides leverage and choice in hardware
purchase decisions for Life Sciences organizations.
The use of multiple generations of servers and the use of
servers from different manufacturers is fully supported by
the QuantaStor SDS platform, which enables organizations
to grow their storage grid(s) on demand, at the best price,
and without the procurement delays and high capital
expenditures of traditional proprietary SAN/NAS solutions.
QuantaStor SDS scales to over 60PB per grid which is
essential to addressing the data growth and data security
challenges surrounding Life Sciences and at an average
savings of 50% or more versus traditional solutions,
QuantaStor enables organizations to collect more data and
retain it longer so that deep analytics can be done in active
and future research.
Insightful Innovation
Steven Umbehocker, Founder and CEO of OSNEXUS
brings over twenty years of experience in the enterprise
storage software industry to the challenges of hyper-scale
storage management. He currently holds over 20 patents in
Storage Systems Technology, SDS, and Cloud Computing,
and has previously led engineering teams at some of the
world’s largest IT companies, including Citrix Systems,
Symantec, and Veritas Software.
In 2009, Steven was leading the development of new
enterprise storage management technologies for XenServer
and saw the need for a new kind of storage system that
would scale as a grid across sites and datacenters in order to
eliminate the complexity and scalability issues inherent to
traditional storage systems. The result of that vision was the
founding of Open Storage Nexus (OSNEXUS) in 2010 and
the creation of QuantaStor SDS with a team of storage
veterans from Veritas and Citrix.
A Unified Data Store
QuantaStor SDS is OSNEXUS’ flagship product and offers
file, block, and object storage in a single system. Besides
QuantaStor, OSNEXUS provides primary product-specific
services, including Virtual Storage Appliances (VSAs)
available in the Microsoft Azure cloud. VSAs are
virtualized instances of QuantaStor SDS which may be
added to storage grids made up of both physical and other
virtual appliances.
OSNEXUS also offers the QuantaStor SDS Cloud License
Service, which gives customers the convenience of self-
provisioning license keys. IT professionals from the Life
OSNEXUS:A Leading Hyper-Scale Software Defined Storage
Provider for Life Sciences
30 January 2018
33. Sciences sector find this solution especially useful because
it enables their IT organizations to quickly scale, deploy,
and redeploy appliances to a multitude of research projects
with ease.
Distinctive Features
QuantaStor SDS is an all-in-one solution that meets the
needs of a variety of different industries and use case
scenarios including server virtualization, big data, cloud
computing, and high-performance applications through
scale-out physical and virtual storage appliances.
Data is protected using end-to-end encryption, which
combines data-at-rest encryption which is AES-NI
accelerated combined with protocol-level/on-the-wire
encryption with SMB, IPsec, and HTTPS across any
storage grid.
QuantaStor provides Pharmaceutical and Life Sciences
organizations the data transfer speed necessary for
accessing, collaborating on, and managing massive amounts
of structured and unstructured scientific data, backup and
migration strategies, object storage, genome-based file
access, encryption, and compliance.
OSNEXUS features like hardware and software disk drive
encryption with Intel AES-NI technology and advanced
user security with role-based access controls are unmatched
in the market. QuantaStor SDS is protected against system
failure through replication, and incorporates expedited
disaster recovery mechanisms like data snapshots.
The Future of Storage
Many companies use public clouds to store their data,
which seem like a low-cost option for data storage. In
industries like Life Sciences, however, when petabytes (one
million gigabytes) of data are produced, public clouds are
Steven Umbehocker
Founder & CEO
Unify, Simplify,
and Automate your
data with
QuantaStor SDS
‘‘
‘‘
not economical. As an example, Amazon Web Services
charges $0.03/GB per month, which is $0.36/GB per year
which equates to $360/TB per year. At the scale of one
petabyte that amounts to $360,000/year or $1.8 millon over
5 years.
In contrast, a dedicated QuantaStor solution including
hardware, software, and cloud-hosting would save as much
as 75% or more versus AWS S3 or other cloud object
storage services. That’s before transfer costs are factored in,
and when one accounts for the need for researchers to run
advanced analytics applications against the data - the
savings can easily come to over 90% versus AWS.
Looking Ahead
OSNEXUS has grown organically at a terrific pace since its
inception in 2010. In its early days, the company focused on
developing its innovative QuantaStor SDS, engineering and
creating an unbeatable open storage platform. Today,
OSNEXUS continues to expand the capabilities of
QuantaStor SDS at an even faster pace with new
innovations in security, data replication, and application
integration.In the coming years, QuantaStor will also
include data integration features into the SDS grid
architecture, which will improve users’ decision-making
ability by reducing the complexity of information available.
QuantaStor SDS users will be able to utilize visual tools
like graphs, charts, and dashboards to better understand
their storage, and simplify capacity planning accordingly.
QuantaStor SDS is available worldwide from a network of
partner resellers and distributors and OSNEXUS has been
helping industry giants like IBM, Cisco, CenturyLink, Intel,
and Microsoft bring SDS innovations to their customers.
The company aims to sustain and build upon these strong
partnerships to expand their world-class, practical open
storage technology.
31
1
M O S T I N N O V A T I V E
SOLUTION PROVIDERS 2018
H RM
L FE SC ENCES
&The
January 2018
34. HOSPITAL
LOGISTICS:
ACCELERATING
THE PATIENT
FLOW IN DANISH
HOSPITALS
For more than a decade hospital productivity has been a priority in
Denmark. A focus on quality and quality improvements has reduced
the rate of re-admittance to Danish hospitals and a demand from
central authorities on hospitals to increase their productivity by 2% every
year, has during recent years resulted in a lot of new initiatives and
innovations. With a re-organization of the Danish hospital structure, this has
led to a total productivity increase of 30% since 2003.
The concept of Hospital Logistics and Solutions to improve logistics and
create just-in-time scenarios in hospitals is another factor behind the
productivity increase which is further explained in this article.
Healthcare systems around the world are challenged by an increased share of
elderly citizens and chronically ill patients as well as more expensive forms of
treatment.
These factors are causing a significant demand pull in terms of treatment
needs as well as expectations, which accentuate the need for our healthcare
systems to work smarter on all levels. Therefore, hospitals need to consider
means to increase efficiency and productivity in order to be able to treat more
patients without increasing costs.
For more than a decade, Danish hospitals
and companies have worked together on
improving logistics in hospitals. The overall
aim has been the creation of just-in-time
solutions in order to optimize coordination
and efficiency and reduce the patients’
length of stay.
In Denmark, the focus on hospital logistics
has played an important role in achieving a
30 pct. increase in hospital productivity
since 2003. Optimizing hospital logistics
within different areas of hospital services
and needs, including supply logistics,
clinical logistics, sterile goods and sample
logistics can accelerate the patient flow and
lead to increasing hospital productivity.
‘Just-in-time’ logistics
Innovative hospital logistics solutions are
already implemented in Danish hospitals in
Health POV
January 201832
35. order to reduce delays and waiting in
order to speed up the patient flow.
At the New Aarhus University
Hospital, a fine-meshed IT system will
enable real-time localization of people
and equipment right down to room
level.
At Aalborg University Hospital, the
introduction of a similar and new
solution has resulted in a close to
20 pct. efficiency increase.
Danish solutions for just-in-time
logistics include systems for locating
and tracking staff and equipment,
solutions for automating basic and
repetitive tasks, as well as solutions for
guiding patients around the hospital, all
of which help avoid delays and peak
times in the hospital process.
Sample logistics
Accelerating the patient flow is also
about reducing the time from taking a
lab test and until the result is ready at
the point of care.
At Hospital of Southern Jutland in
Aabenraa, the number of patients has
increased by 13 pct., but with the new
sample logistics solution, the hospital
has managed to cope and even reduce
the average length of stay.
Intelligent solutions for handling
samples help hospitals reduce their
sample turnaround-time and
subsequently speed up patient
diagnostics. Fully automated
laboratories improve sample flow by
handling and sorting all blood samples
without any manual handling, thereby
minimizing the risk of errors and
freeing up time for value-adding tasks
such as patient related work.
Sterile goods and sample logistics
The Capital Region in Denmark will
centralize all handling of sterile goods
at two departments at Rigs hospitalet
and Herlev Hospital. With fully
automated handling of sterile
equipment, the two centers will
improve hygiene and reduce the risk of
infections. At the same time the budget
for purchasing and storing sterile
equipment will be reduced because of
the just-in-time solution.
The future
Integrated logistics is the next step.
Automatic delivery of medicine from
the hospital pharmacy directly to the
wards and just-in-time housekeeping,
based on the hospital discharge system,
is already a reality in Danish hospitals.
Storage space, which is built directly
into the hospital walls, will prioritize
short walking distances, large coherent
clinical areas and patient related
functions.
Denmark is in the process of building
16 new highly specialized hospitals
that are all constructed as hospitals of
the future, taking into account the
changing role of hospitals in our future
healthcare system. While optimal
hospital logistics is important for all
existing hospitals, it is vital for the
new, large and specialized hospitals.
Hans Erik Henriksen
Chief Executive Officer
Healthcare Denmark
January 2018 33
36. Adding Mobility toAdding Mobility to
HEALTHCAREHEALTHCARE
Via EMR - EHRVia EMR - EHRn the quest of reducing the bulk process involved in
Ihandling the affairs of patients by the medical
practitioners, and to facility the process of getting close
to hands the information which may be needed at the time
of proper examination of patients, the federal laws
governing wings called for the use of EMRs to design new
ways to deliver and improve health care. Some experts say
the government mandates are needed to facilitate, while
others view them as obstacles.
When you are to implement a secure and an efficient system
to manage medical records and generate invoices at your
office. It will pay off better if you consider going paperless
when managing electronic medical records to reduce the
distance between you and the files you may need at the
moment. Going paperless have the very potential of
streamlining the numerous internal operations and possibly
improve the patient experience.
The Benefits of EMR According to the Experts:
Improved Safety: The implementation of terms in EMRs
has the potentiality of reducing medical errors caused by
outright handwriting. Assuming a patient was given a
prescription by the doctor and the patient is found to be
allergic to Medication, through EMR systems, the health
firm and patient can get an alert or medication may
harmfully interfere with another drug the patient is already
taking.
Affordable Health Care: With the possible
implementation Health Information Technology terms, the
costs of health can be reduced by preventing the duplication
of expensive medical tests. The health care team can easily
gain access to a patient’s medical record in real time to
determine if costly procedures like magnetic resonance
imaging or computed tomography scans have already been
done.
Advanced Communication: Medical records that can be
accessed by smartphones, tablets, and computers makes it
easy for patients and health care providers to filter medical
histories, email questions, look up laboratory results, and
schedule office visits in terms of preventive and follow-up
care.
“Electronic health record helps to increase the speed and
reliability in the communication and dialogue between the
health care team, family members, and patients. For
instance, some children who live thousands of miles away
who can benefit from the care of their folks using electronic
health records,” says Salvatore Volpe, a primary care
physician in Staten Island, New York. Salvatore Volpe the
chairman of the health information technology committee at
the Medical Society of New York.
Participative Patients: According to the National
Partnership survey it was recorded that patients who take
more time accessing their health information online were
more motivated to act towards improving their health
(About 71 percent of frequent users, compared with 39
percent of the infrequent users). At Volpe’s practice, you
will find iPads which are used by the patients to access the
internet for their medical records and visit websites to learn
more about their medical conditions.
Improved community health: Health information
technology has been proved to improve the possibilities of
aiding overall health of more than one person but also, a
Exclusive
January 201834
37. whole community by identifying health disparities, tracking trends, monitoring the use of preventive care and helping
patients to manage issues that tend to be chronic. For example, EMRs providers can use these systems to identify and notify
patients who are due to take actions towards preventive solutions, including colonoscopies, mammograms, prostate cancer
screenings or diabetic foot exams.
The Critical Concern in EMR
It's tough to imagine an industry of new generation that doesn't rely on computers and customized software to keep an eye on
employees and thereby ensure that employees can work more productively and effectively. Computerization is very much
required in the field of medicine as this will help to manage the enormous volume of data that medical practitioners,
hospitals, and clinics create and store for individual patients. EHR software saves time and money, and helps in instant
communication with hospitals, insurers, and referring physicians.
It is very relevant that a medical practice manager or owner of any such establishment to desire the involvement in the
procedure of evaluating the possible benefits and also the drawbacks of implementing the concept of EHR solutions before
total commitment and possibly installing the system in his / her premises.
January 2018 35
38. Insight into The Future of EMR
There is rapid change which is taking place in the health information technology industry, as cited by Dr. Glenn Tucker, a
prominent internist with Attleboro Medical Associates situated in Attleboro, Massachusetts, and the chairman of the
information technology committee at the Massachusetts Medical Society, in his opinion said that some mandates have “stifled
innovation.”
“It will please me to see more [vendor] innovation in the area of usability, and this means how easy it will be for a physician
to use the EMR or EHR system to provide better, safer care that will be more efficient,” he said. “Interoperability tends to be
another concern. The ability to send information, easily across the street to someone who is using a different electronic
system is next to impossible.”
Despite the challenges which the growth of EMR systems, terms and procedures is facing, there is also a good number of
physicians through their resistance is indirectly giving importance to the use of these systems and this will possibly take over
the comfort mind of the new generation of medical professionals.
“Change in this field is inevitable as we graduate to more of the Xbox-Play Station, Smartphone and tablet generation.”
Nothing that electronic medical record is a digital version of the formal method of medical documentation which is “Paper
Based” and everybody is becoming so interested in reducing the amount of paper that will be involved in their work, it’s
obvious that a good number of the health Industries will be taking part in the implementation of EMR and EHR solutions.
Exclusive
January 201836
41. echnology in healthcare has never been more important than is today, and its role is growing by the hour. The
Tindustry has moved from lab screen analysis, record keeping, and claims processing into the realm of ‘Big Data’,
machine learning, predictive analytics, and far beyond. Rapidly-evolving technology is contributing in significant
ways to measure and reduce healthcare costs and improve care quality. Let me illustrate with an example from one
company, DataSmart Solutions.
DataSmart aggregates and analyzes medical and pharmacy claims data (and other important supplemental types of data
outlined below) to create a statistically-reliable risk score for individuals that belong to employer health plans. These risk
®
scores, produced in conjunction with the Johns Hopkins University ACG system, are forward-looking, or predictive, in
nature. The goal of the analysis is to spot emerging high-cost claimants well before their condition deteriorates and
becomes advanced or life-threatening.
Once risk scores are assigned to each plan participants, nurse clinicians and population risk managers prioritize the
participants and deploy intervention resources in descending order, addressing the highest risk plan participants. In this
manner, health care professionals prevent higher risk cases from escalating into major crises and higher expenses for the
plan.
Lastly, a careful study of the data enables important refinements to be made to benefit plans to encourage higher
utilization of the highest-value medications, the best facilities, and the best providers.
Interestingly, Pareto’s Law (also known as the ‘80/20 Rule’) appears in dramatic fashion in population risk management
and healthcare. In short, a small percentage of the covered lives accounts for a disproportionate share of plan expenses.
Most wellness programs focus efforts upon the masses (i.e. the 80%). However, in actuality, most of a plan’s expenses
originate with a small number of plan participants (i.e. the 20%). In fact, as few as 3-5% of plan participants routinely
account for one-half of a health plan’s expenses, somewhat regardless of the plan, the geography, or the demographics of
the population. Imagine the impact on health that could be realized if the 3-5% could prevent their condition from
deteriorating. Early detection of this small percentage also presents a great opportunity to lower the overall cost of care.
Diabetes, cardiac conditions, and even some cancers can be readily identified in early states by the pro-active use of
predictive analytics.
A similar statistic of similar importance relates to the non-repetitive nature of high cost claimants. Approximately 60%
of those appearing on list of highest-cost claimants in a given plan year appear on this list for the first time. In short, the
majority of the highest-cost claimants from year-to-year are new to the list. This creates a challenge, because medical and
pharmacy claims data does not exist for many lives on the plan, and even if it did, it would not provide sufficient data to
predict future risk. Further, approximately 20% of plan participants will not enter the medical system in any given year,
and within that group, there are many ticking time bombs.
To address this problem, plan managers often include financial incentives to participants to encourage them to engage in
activities that generate usable, statistically-significant data. Valuable sources of data include blood screens, biometric
information, vision tests and special health risk questionnaires. As this data is collected and analyzed, it can serve as a
surrogate for medical claims. Today, leading edge analytics companies have found that many non-claims elements are
less-expensive, more accessible, and more statistically-valuable than claims records. In short, the more relevant data
available, the better.
As a final thought, the actions taken [upon analytically-derived findings] are at least as important as the findings
themselves. Those who lay these risk markers aside are no better off than a person who fails to follow his own advice.
The scientist James E. Talmage once told an unconfirmed, but illustrative, story involving “…an epidemic of cholera in a
great city in which a scientific man proved to his own satisfaction, by chemical and microscopic tests, that the water
supply was infected, and that through it contagion was being spread. He proclaimed the fact throughout the city, and
warned all against the use of un-boiled water. Many of the people, although incapable of comprehending his methods of
investigation, far less of repeating such for themselves, had faith in his warning words, followed his instructions, and
escaped the death to which their careless and unbelieving fellows succumbed. Nevertheless, in a moment of forgetfulness
he drank of the unsterilized water, and soon thereafter died, a victim to the plague.”
The moral to the story is that information is only as valuable as the measures taken to act upon it. Nowhere is this more
true and applicable than in healthcare.
January 2018 39
42. The Next Frontier
of INNOVATION in the
Pharmaceutical
Industry
The pharmaceutical industry is passing through hopeful and turbulent times at the same time today. On one hand, the
industry is facing rising opposition from customers who wish to pay as a single payer. On the other hand, great
innovations are helping pharmaceutical industry meet new customers to grow revenues. An example of the later
development is the digital mobile technology which helps the industry collect large amount of data to form an unparalleled
understanding of healthcare. Additionally, today the pharmaceutical industry is in a position to make a statement to the larger
public to seal its place as the ideal provider of healthcare in the long run. The Pharmaceutical industry can find a harmonious
balance between the turbulence and opportunities to claim the throne of a great healthcare provider with real innovation
today.
Currently, the healthcare industry focuses on R&D which can immediately be turned into products to earn revenues. An
example of this economic development is the large number of medical solutions available which treat common illnesses such
as cold, fever, headache, etc. and are usually available as over the counter medicine for patients. This economic activity is
governed by patients who pay as individuals. This economic model is in line with natural principles that advocate that self-
interest is the motivator of economic activity and competition is the regulator. However, there is a new economic expectation
of patients which could better shape the future. If patients paid as a single payer, the government could invest in more R&D
tax dollars into the future in the form of grants or subsidies. Without the infusion of such investments, real innovation would
be difficult as real innovation requires companies to operate in the area of absolute uncertainty, which can be a nightmare
from the point of view of shareholders.
Untapped Innovative Opportunities
In the pharmaceutical sector, the natural economic forces have not yet found solution to deadly diseases like HIV, multiple
forms of cancers, and several others. The primary reason for true lifesaving innovation being expensive is that true innovation
operates in the territory of absolute uncertainty and hence one cannot set a timeline in principle in order to achieve desired
results. Furthermore, this is also the primary reason why deadly diseases which promise lucrative revenues may never see
real investment by individuals who are governed by self-interest. Individual self-interest leaves breathing space for Individual
desire for happiness and is likely to be susceptible to individual weaknesses. On the other hand, if companies received
funding for innovation through a legitimate public entity like the government, it could invest in innovation for the long term
January 201840
Care & Cure
43. growth of a society. Such collaboration would help the
pharmaceutical industry to find solutions that separate life
and death in a meaningful manner in the society. On the
other hand, the individual companies which find a solution
to grave illnesses can also monetize these innovations.
Some such trending innovations are mentioned below.
Precise Medicine
Today the Pharmaceutical industry faces stiff legal penalties
for overdosing a patient with a particular medicine. The
good news is soon doctors would gain access to genomes
which helps map out the individual medical history. This
makes it possible to deliver a perfect and precise dose of
medicine to a patient. Genome projects are gathering
momentum, largely due to an initiative of the Obama
administration, which gave the grant of $215 million to
Precision Medicine Initiative. Grants like these and
projects like these would make it possible to develop
personalized medical solutions which are near perfect for
all patients.
Data Gathering
It is important for doctors and medical researchers to have
access to real intelligent data in order to make objective
observations and produce insightful innovation. Such data
gathering and generation has become much easier thanks to
mobile apps. Today, several mobile phones include
technologies that can track movement, sense various health
indicators and measure the health of patients and provide
the data to doctors and researchers to better understand their
patients. Such data apps are making it possible to create
gene sequencing and live health monitoring, which could
have only been dreamt about in the past.
Artificial Intelligence (AI)
AI has become the guiding light for many industries. The
Pharmaceutical industry is not an exception to this rule.
Supercomputers and machine learning are making it
possible for researchers to detect patterns in genes, diseases
and respond to them with appropriate solutions at a blazing
quick speed. Many such AI projects are currently helping
the Pharmaceutical industry on the path of innovation. One
prime example of this technology in action is the IBM
Watson which has demonstrated learning capabilities and
absorbs millions of pages of medical literature to make the
industry reach the pinnacle of competitive success.
There are many more innovations which are reshaping the
future of the Pharmaceutical industry. Some of these
include 3D Printing, Nanotechnology, Virtual meetings
between doctors and patients, etc. Innovation is opening up
new doors of opportunities for every industry and
companies which follow the path of innovation will find a
golden arch to build a great future for them. However, it is
important for the industry to secure its long term interest by
positioning itself as the ideal provider of healthcare services
in the short run.
Precise Medicine
Articial Intelligence
Data Gathering
January 2018 41
44. Life science organizations are confronting a heap
of pressure from investors, stakeholders,
regulatory experts, patients, and the healthcare
industry as they are expected to produce high-quality
medical products around the globe. As a result,
organizations turn to outsourcing vendors to help them
address these constraints. However, their requirements
have grown significantly in the last decade as they seek
greater scientific knowledge and innovation capabilities
than what customary Business Process Organizations
(BPOs) or Contract Research Organizations (CROs) are
able to offer.
Sciformix, a leading scientific knowledge-based
organization, is filling the gaps left by these providers to
provide a higher level of engagement, quality and value
due to its thought leadership, deep domain knowledge,
and technology innovation. Founded over a decade ago,
Sciformix has been able to successfully provide process,
technology, and consulting services to
biopharmaceutical, generic pharmaceutical, consumer
products, medical devices, and other healthcare
companies. Today, Sciformix’s ability to integrate
scientific and technology expertise with quality driven
processes provides value to its clients throughout the
entire drug development cycle. Their clients are gaining
an upper hand and are poised to witness greater success
and business focus by proactively managing their
products with state-of-the-art technology and best-in-
class services.
Amid its varied range of specialized services, some areas
that distinguish Sciformix are Safety & Risk
Management, Clinical Development, Regulatory Affairs
& Regulatory Operations, Real World Evidence &
Market Access, and Technology Services. The company
helps clients accelerate their business, drive higher levels
of performance and facilitate innovation by employing
best-in-class strategies, technologies and expertise.
A Vision that Paved the Way for Growth
The founders of the company—Ajit Nagral, Founder &
Chairman, and Chitra Lele, Co-founder & Chief
Scientific Officer—had the vision of establishing a
company that would provide specialized science-based
services to pharmaceutical organizations. Although, the
founders initially focused on offerings in Safety & Risk
Management and Biometrics, they gradually expanded to
include Medical Writing and Regulatory Affairs to
support their clients’ growing needs. Soon enough, they
introduced Clinical Development, Real World Evidence
& Market Access and Technology Services, greatly
expanding their offerings and expertise.
Headquartered in the US, Sciformix has operations in
Europe, India and the Philippines. By employing over
1,000 experts around the world with diverse skill-sets,
Sciformix is able to offers its clients flexible and cost-
effective deployment models (on-shore, off-shore and
hybrid) to meet their unique needs. Sciformix is
recognized by the industry for its depth of scientific
expertise.
Singularly Dedicated to the Life Science Industry
Through all these years, though, the mission of the
Company—to partner with life science companies to
provide high quality scientific expertise that delivers
better quality outcomes and improved efficiencies across
the entire product lifecycle with the ultimate objective of
improving quality of healthcare for patients
worldwide—hasn’t changed a bit.
Since its foundation Sciformix has been singularly
dedicated to the life science industry. Therefore, its
Sciformix:
Driving Innovation Through Deep Scientific
Knowledge and Technology Expertise
January 201842
45. people, processes, and technologies have been tailored
and optimized to meet the industry’s unique needs.
Quality, compliance, and scientific excellence are the
company’s cornerstones and its experienced subject
matter experts (SMEs) and thought leaders are a clear
differentiator, enabling Sciformix to provide unique
insight and value to its clients. The company delivers
consistent quality and compliance across its services by
employing scientific rigor in combination with
streamlined processes, optimal technology, and efficient
people practices.
One of the major challenges organizations face today is
how to effectively integrate the complexities of two
seemingly disparate functions - technology and science -
across all phases of the product development life cycle.
Typically, outsourcing organizations excel in one or the
other, but not both. Sciformix has recognized the
synergies of an integrated strategy and unified
communication process to help its clients deploy
technology for better insight, analytics, and compliance.
Diversification, Growth and Global Reach
Sciformix’s long-term strategy focuses on evolving and
enhancing its service and technology offerings,
broadening its global reach and growing and diversifying
its client and revenue base. This can be seen in the recent
launch of several cloud based safety technology service
offerings and expansion of its presence in Europe with a
new call center operation in Romania. Sciformix is also
looking to penetrate underserved markets in Asia Pacific
such as South Korea and Taiwan. In addition, the
biosimilars market is expected to grow to $20B by 2020
and companies will need Sciformix’s support to enter
both established and emerging markets. Sciformix is
looking at this market astutely as an area of growth and
further expansion.
Meet the CEO
Manish Vinayak Soman, President and CEO of
Sciformix has over 26 years of proven experience in
overseeing IT operations that encompass
program/project management, consulting services,
systems development & implementation and business
operations; and has managed P&L’s and Balance Sheets
for over 15 years. He has held leadership positions
across multiple geographies. His past experience
includes tenures as CEO & Managing Director of
Deloitte India, Global Business Leader for IT at Genpact
(formerly a GE company), COO for Patni Computers
and Director for BestShore Operations in EMEA for HP
Enterprise Services.
www.sciformix.com
Manish Soman
President & CEO
Our experts, physicians,
scientists, and statisticians dive
deep into data to provide thorough
analysis and insight to help clients
make faster and more informed decisions
so that they can deliver safer and
more effective medical products
around the world.
‘‘
‘‘
January 2018 43
1
M O S T I N N O V A T I V E
SOLUTION PROVIDERS 2018
H RM
L FE SC ENCES
&The